Clinical course of lung cancer in patients with chronic kidney disease

Lung Cancer

Volumn 43, Issue 3, 2004, Pages 297-300

  Patel, Purvi ^a   Henry, Lisa L ^c   Ganti, Apar Kishor ^b   Potti, Anil ^c  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

^c NONE

Author keywords

CKD; Kidney disfunction; Non small cell lung cancer; Small cell lung cancer

Indexed keywords

CANCER CYTODIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COMORBIDITY; DISEASE COURSE; DYSPNEA; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SURVIVAL RATE; THORAX PAIN; WEIGHT REDUCTION;

EID: 1242328769     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2003.08.029     Document Type: Article

References (15)

1. Thomas Jr CR, Williams TE, Cobos E, Turrisi III. AT. Lung Cancer. In: Lenhard RE, Osteen RT, Gansler T, editors. Clinical Oncology. 1st ed. American Cancer Society; 2001. p. 269-97.
2. Travis W.D., Lubin J., Ries L., Devesa S. United States lung cancer incidence trends. Cancer. 77:1996;2464-2470.
3. Parkin D.M., Pisani D., Perlay P. Estimates of the worldwide incidence of eighteen major cancers in 1985: Implications for prevention and projections of future burden. Int. J. Cancer. 55:1993;891-903.
4. Jemal A., Thomas A., Murray T., Thun M. Cancer Statistics 2002. CA Cancer J. Clin. 52:2002;23-47.
5. Minna JD. Neoplasms of the lung. In: Braunwald E, Fauci AS, Kasper DL, et al., editors. Harrison's principles of internal medicine. 15th ed. New York: McGraw-Hill. p. 562-71.
6. Tammemagi C.M., Neslund-Dudas C., Simoff M., Kvale P. Impact of co-morbidity on lung cancer survival. Int. J. Cancer. 103:2003;792-802.
7. Vamvakas S., Bahner U., Heidland A. Cancer in end-stage renal disease: potential factors involved. Am. J. Nephrol. 18:1998;89-95.
8. Bilello K.S., Murin S., Matthay R.A. Epidemiology, etiology, and prevention of lung cancer. Clin. Chest Med. 23:2002;1-25.
9. Maisonneuve P., Agodoa L., Gellert R.et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 354:1999;93-99.
10. Midthun DE, Jett JR. Clinical presentation of lung cancer. In: Pass HI, et al., editors. Lung cancer: principles and practice. Philadelphia: Lippincott-Raven; 1996, p. 421.
11. Brownson R.C., Chang J.C., Davis J.R. Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiology. 3:1992;61-64.
12. Osann K.E., Anton-Culver N., Kurosaki T.et al. Sex differences in lung cancer risk associated with cigarette smoking. Int. J. Cancer. 54:1993;44-48.
13. Lassen U, Hansen HH. Small cell carcinoma of the lung. In: Haskells CM, editor. Cancer treatment. Philadelphia: Saunders; 1995. p. 414-20.
14. Non-small cell lung cancer. NCCN® Practice Guidelines in Oncology, vol. 1; 2002.
15. Small cell lung cancer. NCCN® Practice Guidelines in Oncology, vol. 1; 2002.